Works matching IS 15747891 AND DT 2025 AND VI 19 AND IP 5


Results: 19
    1

    Issue Information.

    Published in:
    Molecular Oncology, 2025, v. 19, n. 5, p. 1285, doi. 10.1002/1878-0261.70052
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO‐OV‐UMB1/ENGOT‐OV30 trial.

    Published in:
    Molecular Oncology, 2025, v. 19, n. 5, p. 1436, doi. 10.1002/1878-0261.13811
    By:
    • Tandaric, Luka;
    • Auranen, Annika;
    • Kleinmanns, Katrin;
    • DePont Christensen, René;
    • Vestrheim Thomsen, Liv Cecilie;
    • Wogsland, Cara Ellen;
    • McCormack, Emmet;
    • Mäenpää, Johanna;
    • Madsen, Kristine;
    • Stampe Petersson, Karen;
    • Mirza, Mansoor Raza;
    • Bjørge, Line
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    On‐treatment dynamics of circulating extracellular vesicles in the first‐line setting of patients with advanced non‐small cell lung cancer: the LEXOVE prospective study.

    Published in:
    Molecular Oncology, 2025, v. 19, n. 5, p. 1422, doi. 10.1002/1878-0261.13737
    By:
    • Gristina, Valerio;
    • Bazan, Viviana;
    • Barraco, Nadia;
    • Taverna, Simona;
    • Manno, Mauro;
    • Raccosta, Samuele;
    • Carreca, Anna Paola;
    • Bono, Marco;
    • Bazan Russo, Tancredi Didier;
    • Pepe, Francesco;
    • Pisapia, Pasquale;
    • Incorvaia, Lorena;
    • Badalamenti, Giuseppe;
    • Troncone, Giancarlo;
    • Malapelle, Umberto;
    • Santini, Daniele;
    • Russo, Antonio;
    • Galvano, Antonio
    Publication type:
    Article